Greater Green Tea, Coffee Consumption Associated With Lower Mortality Risk in T2D Population

October 22nd 2020, 1:45pm


Consuming more green tea and coffee was associated with reduced all-cause mortality among individuals with type 2 diabetes (T2D), according to the results of a prospective study published in BMJ Open Diabetes Research and Care.

Survey Highlights Challenges of Diabetes Management, Potential Impact of Technology

October 19th 2020, 4:38pm


Results from a national survey conducted by the Association of Diabetes Care & Education Specialists show that individuals living with diabetes feel they are doing everything they can to manage the condition, yet believe more can be done.

Diabetes Risk Factors Dominate Top Causes of Global Mortality, Heighten COVID-19 Risks

October 15th 2020, 10:30pm


New data estimates from the Global Burden of Disease Study published by The Lancet illustrate how rising rates of chronic disease and public health failures compounded over decades to worsen the coronavirus disease 2019 (COVID-19) pandemic.

Can an HIV Drug Help Prevent Diabetes?

October 12th 2020, 7:00pm


Patients who received anti-inflammasome nucleoside reverse-transcriptase inhibitors (NRTIs)—drugs approved to treat HIV-1 and hepatitis B infections—exhibited a 33% reduced risk of developing type 2 diabetes (T2D), according to a meta-analysis published in Nature Communications.

What We’re Reading: Nobel Prize in Chemistry Awarded; Improving Diabetes Management; COVID-19 Vaccine Trial Still on Hold

October 7th 2020, 2:45pm


Two women are awarded the Nobel Prize in Chemistry for CRISPR; Eli Lilly partners with DexCom, Inc; the US arm of AstraZeneca’s coronavirus disease 2019 (COVID-19) vaccine trial remains halted.

Study Highlights Persistent Racial Disparities in Insulin Pump Use Among Children With T1D

October 6th 2020, 4:07pm


Racial disparities in insulin pump use among children with type 1 diabetes (T1D) have persisted over the past 15 years, independent of socioeconomic status.

NIH Funds First Network to Study Rare Forms of Diabetes

October 5th 2020, 4:30pm


The National Insistutes of Health (NIH) study aims to discover new forms of diabetes, understand what makes them unique, and identify root causes.

Diabetes Drug May Hold Potential as COVID-19 Treatment

September 29th 2020, 5:30pm


In patients with type 2 diabetes admitted to the hospital for coronavirus disease 2019 (COVID-19), treatment with sitagliptin at the time of hospitalization was associated with reduced mortality and improved clinical outcomes compared with standard-of-care treatment.

Progress Made in Diabetes Technology Coverage, Access Among Medicare Beneficiaries

September 28th 2020, 5:15pm


Recently, 2 district courts secured a pair of victories for Medicare beneficiaries who use continuous glucose monitor technologies to manage their diabetes, while senators introduced bipartisan legislation aimed at increasing access to the Medicare Diabetes Prevention Program.

Ertugliflozin CV Outcomes in T2D Population Are Similar to Placebo

September 23rd 2020, 9:00pm


In patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease, results from a multicenter, double-blind trial show that treatment with ertugliflozin is noninferior to placebo with respect to major adverse cardiovascular events.